{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:03:09Z","timestamp":1791406989367,"version":"4.3.3"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2U54GM104942-07"],"award-info":[{"award-number":["2U54GM104942-07"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100028773","name":"National Association of Chronic Disease Directors","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["OT18- 1802"],"award-info":[{"award-number":["OT18- 1802"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.japh.2024.102309","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T07:40:32Z","timestamp":1734162032000},"page":"102309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Implementing a telemedicine-led heart failure medication regimen optimization clinic in medically underserved heart failure populations"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-8025","authenticated-orcid":false,"given":"Kazuhiko","family":"Kido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-0148","authenticated-orcid":false,"given":"George","family":"Sokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.japh.2024.102309_bib1","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.japh.2024.102309_bib2","article-title":"West Virginia nonmetro population","year":"2024","journal-title":"Rural Health Inf Hub"},{"issue":"6","key":"10.1016\/j.japh.2024.102309_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamainternmed.2024.1523","article-title":"Telephone-based guideline-directed medical therapy optimization in navajo nation: the H\u00f3zh\u00f3 randomized clinical trial","volume":"184","author":"Eberly","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.japh.2024.102309_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2024.02.008","article-title":"The effect of using a remote patient management platform in optimizing guideline-directed medical therapy in heart failure patients: a randomized controlled trial","volume":"12","author":"Brahmbhatt","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.japh.2024.102309_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamacardio.2023.5627","article-title":"Interventions for optimization of guideline-directed medical therapy: a systematic review","volume":"9","author":"Tang","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.japh.2024.102309_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.japh.2024.102309_bib7","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ejhf.2287","article-title":"Stopping mineralocorticoid receptor antagonists after hyperkalemia: trial emulation in data from routine care","volume":"23","author":"Trevisan","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.japh.2024.102309_bib8","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.cardfail.2022.05.014","article-title":"Can we stop reflectively discontinuing mineralocorticoid antagonists for patients with heart failure and hyperkalemia?","volume":"28","author":"Mastoris","year":"2022","journal-title":"J\u00a0Card Fail"},{"issue":"14","key":"10.1016\/j.japh.2024.102309_bib9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jacc.2023.02.005","article-title":"Cluster-randomized trial comparing ambulatory decision support tools to improve heart failure care","volume":"81","author":"Mukhopadhyay","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.japh.2024.102309_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.120.051863","article-title":"An electronically delivered patient-activation tool for intensification of medications for chronic heart failure with reduced ejection fraction: the EPIC-HF trial","volume":"143","author":"Allen","year":"2021","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.japh.2024.102309_bib11","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS study group","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.japh.2024.102309_bib12","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart disease. MOCHA investigators","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.japh.2024.102309_bib13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1060028020983522","article-title":"Evaluating sacubitril\/valsartan dose dependence on clinical outcomes in patients with heart failure with reduced ejection fraction","volume":"55","author":"Kido","year":"2021","journal-title":"Ann Pharmacother"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124003406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124003406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T12:34:17Z","timestamp":1739795657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124003406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1544319124003406"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102309","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing a telemedicine-led heart failure medication regimen optimization clinic in medically underserved heart failure populations","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102309"}}